Inspire Medical Systems Inc
INSP
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.22B
Close$
$162.10
114.1% upside
Current Fair Value
114.1% upsideUndervalued by 114.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.22 Billion |
|---|---|
| Enterprise Value | $2.12 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.95 |
| Beta | 0.7 |
| Outstanding Shares | 28,835,058 |
Return
| Return on Equity | 16.36% |
|---|---|
| Return on Assets | 14.58% |
| Return on Invested Capital | 5.76% |
Valuation & Multiples
| P/E Ratio | 16.47 |
|---|---|
| PEG | -15.15 |
| Price to Sales | 2.44 |
| Price to Book Ratio | 2.7 |
| Enterprise Value to Revenue | 2.36 |
| Enterprise Value to EBIT | 43.1 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$194.72 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$204.16 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.4189▼ 211.23% |
|---|---|
| Total Calls | 103,600▲ 24.52% |
| Total Puts | 147,000▼ 49.97% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 129.30%▲ 7.78% |
|---|---|
| Total Invested | $1.66B▼ 7.85% |
| Investors Holding | 285▼ 27.00% |
ESG Score
No data
About Inspire Medical Systems Inc
CEO: Timothy Herbert Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and onl...